Prognozy (mln)
| Okres | 2026-03-31 | 2027-03-31 | 2028-03-31 | 2029-03-31 | 2030-03-31 |
| Przychód (średnia) | 100.62 | 118.49 | 142.30 | 157.13 | 176.88 |
| Przychód Δ r/r | 0.00% | 17.76% | 20.09% | 10.42% | 12.57% |
| Przychód (min) | 99.63 | 105.12 | 132.97 | 146.84 | 165.30 |
| Przychód (max) | 101.98 | 128.24 | 149.51 | 165.10 | 185.85 |
| EBITDA (średnia) | 7.30 | 8.59 | 10.32 | 11.39 | 12.83 |
| EBIT (średnia) | -0.59 | -0.69 | -0.83 | -0.92 | -1.03 |
| EBIT % | -0.58% | -0.58% | -0.58% | -0.58% | -0.58% |
| Zysk netto % | -0.99% | 8.53% | 17.76% | 27.91% | 32.69% |
| EPS (średnia) | -0.04 | 0.38 | 0.95 | 1.65 | 2.18 |
| Liczba analityków (Przychody) | 6 | 6 | 2 | 5 | 3 |
| Liczba analityków (EPS) | 3 | 4 | 3 | 2 | 2 |
| symbol | MEDXF | MEDXF | MEDXF | MEDXF | MEDXF |